Cara Therapeutics
CARA
#10881
Rank
NZ$13.86 M
Marketcap
NZ$9.10
Share price
-2.56%
Change (1 day)
20.91%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -NZ$0.11 Billion

According to Cara Therapeutics 's latest financial reports the company's current earnings are NZ$7.13 Million. , an increase over its 2023 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.11 Billion-45.49%
2023 -NZ$0.2 Billion31.6%
2022 -NZ$0.15 Billion-1.74%
2021 -NZ$0.16 Billion-1754.28%
2020 NZ$9.2 M-104.82%
2019 -NZ$0.2 Billion44.32%
2018 -NZ$0.14 Billion30.09%
2017 -NZ$0.11 Billion1.86%
2016 -NZ$99.87 Million131.86%
2015 -NZ$43.08 Million39.38%
2014 -NZ$30.91 Million9120.41%
2013 -NZ$0.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.42 B-41,473.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$18.11 B-16,966.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-NZ$53.11 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.43 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-NZ$0.14 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.47 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-NZ$17.6 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA